Aminoglycosides

Agents


Adverse Effects

Pulmonary Manifestations

  • Neuromuscular Junction Antagonism with Respiratory Muscle Weakness (see Acute Hypoventilation and Chronic Hypoventilation)
    • Risk Factors
      • Intraperitoneal adminsistration
      • Intrapleural administartion
      • CKD
      • Associated use of paralytics
    • Treatment: may respond to physostigmine

Renal Manifestations


References

  • xxx